Causal relationship between circulating glutamine levels and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study

• Published in: BMC pulmonary medicine Vol. 24; no. 1; pp. 451 - 10
• Main Authors: Xu, Tao, Liu, Chengyu, Ning, Xuecong, Gao, Zhiguo, Li, Aimin, Wang, Shengyun, Leng, Lina, Kong, Pinpin, Liu, Pengshuai, Zhang, Shusen, Zhang, Ping
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.09.2024; BMC
• Subjects: Analysis; Care and treatment; Causal relationship; Collagen; Development and progression; Dosage and administration; Genetic aspects; Genetic variation; Genome-Wide Association Study; Glutamine; Glutamine - blood; GWAS; Health aspects; Humans; Idiopathic pulmonary fibrosis; Idiopathic Pulmonary Fibrosis - blood; Idiopathic Pulmonary Fibrosis - genetics; Mendelian randomization; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; Pulmonary fibrosis; Single nucleotide polymorphisms; China; Causal relationship; GWAS; Mendelian randomization; Idiopathic pulmonary fibrosis; Glutamine
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-024-03275-4

Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating respiratory disease with a median survival of less than 5 years. In recent years, glutamine has been reported to be involved in the regulation of collagen deposition and cell proliferation in fibroblasts, thereby influencing the progression of IPF. However, the relationships between glutamine and the incidence, progression, and treatment response of IPF remain unclear. Our study aimed to investigate the relationship between circulating glutamine levels and IPF, as well as its potential as a therapeutic target. We performed a comprehensive Mendelian Randomization (MR) analysis using the most recent genome-wide association study summary-level data. A total of 32 single nucleotide polymorphisms significantly correlated to glutamine levels were identified as instrumental variables. Eight MR analysis methods, including inverse variance weighted, MR-Egger, weighted median, weighted mode, constrained maximum likelihood, contamination mixture, robust adjusted profile score, and debiased inverse-variance weighted method, were used to assess the relationship between glutamine levels with IPF. The inverse variance weighted analysis revealed a significant inverse correlation between glutamine levels and IPF risk (Odds Ratio = 0.750; 95% Confidence Interval : 0.592-0.951; P = 0.017). Sensitivity analyses, including MR-Egger regression and MR-PRESSO global test, confirmed the robustness of our findings, with no evidence of horizontal pleiotropy or heterogeneity. Our study provides novel evidence for a causal relationship between lower circulating glutamine levels and increased risk of IPF. This finding may contribute to the early identification of high-risk individuals for IPF, disease monitoring, and development of targeted therapeutic strategies.